D. Fogarty

First name
D.
Last name
Fogarty
Wilkinson, S. ., Douglas, I. J., Williamson, E. ., Stirnadel-Farrant, H. A., Fogarty, D. ., Pokrajac, A. ., … Tomlinson, L. A. (2018). Factors associated with choice of intensification treatment for type 2 diabetes after metformin monotherapy: a cohort study in UK primary care. Clin Epidemiol. http://doi.org/10.2147/clep.s176142
Wilkinson, S. ., Douglas, I. ., Stirnadel-Farrant, H. ., Fogarty, D. ., Pokrajac, A. ., Smeeth, L. ., & Tomlinson, L. . (2018). Changing use of antidiabetic drugs in the UK: trends in prescribing 2000-2017. BMJ Open. http://doi.org/10.1136/bmjopen-2018-022768
Wilkinson, S. ., Williamson, E. ., Pokrajac, A. ., Fogarty, D. ., Stirnadel-Farrant, H. ., Smeeth, L. ., … Tomlinson, L. A. (2020). Comparative effects of sulfonylureas, DPP4is and SGLT2 inhibitors added to metformin monotherapy: a propensity-score matched cohort study in UK primary care. Diabetes Obes Metab. http://doi.org/10.1111/dom.13970